How To Use HCPCS Code C9456

HCPCS code C9456 describes an injection of isavuconazonium sulfate, with a dosage of 1 mg. This code is used to identify the administration of this specific medication and is typically used in a medical setting. In this article, we will explore the details of HCPCS code C9456, including its official description, procedure, when to use it, billing guidelines, historical information, and Medicare and insurance coverage.

1. What is HCPCS C9456?

HCPCS code C9456 is a specific code used to identify the injection of isavuconazonium sulfate, with a dosage of 1 mg. It is important for medical coders to correctly assign this code when billing for the administration of this medication. This code helps healthcare providers and insurance companies accurately track and categorize the services provided.

2. Official Description

The official description of HCPCS code C9456 is “Injection, isavuconazonium sulfate, 1 mg.” This description clearly indicates the specific medication being administered and the dosage amount. The short description for this code is “Parenteral supp not othrws c,” which provides additional information about the nature of the service.

3. Procedure

1. Prepare the necessary equipment and supplies for the injection.
2. Verify the patient’s identity and confirm the correct medication and dosage.
3. Ensure proper hand hygiene and use appropriate personal protective equipment.
4. Select an appropriate injection site and clean the area with an antiseptic solution.
5. Prepare the medication according to the manufacturer’s instructions.
6. Administer the injection using the appropriate technique and needle size.
7. Dispose of used needles and other sharps in a designated sharps container.
8. Document the administration of the medication in the patient’s medical record.

4. When to use HCPCS code C9456

HCPCS code C9456 should be used when administering isavuconazonium sulfate via injection, with a dosage of 1 mg. It is important to ensure that the medication and dosage match the description provided in the code. This code is typically used in a medical setting, such as a hospital or clinic, where healthcare professionals are authorized to administer injections.

5. Billing Guidelines and Documentation Requirements

When billing for HCPCS code C9456, healthcare providers need to document the administration of isavuconazonium sulfate, including the dosage and any relevant details. It is important to follow the specific billing guidelines provided by insurance companies or Medicare to ensure accurate reimbursement. Proper documentation is crucial for supporting the medical necessity of the service and justifying the use of this specific HCPCS code.

6. Historical Information and Code Maintenance

HCPCS code C9456 was added to the Healthcare Common Procedure Coding System on January 1, 1985. It has an effective date of January 1, 1996. This code has a termination date of December 31, 2015, indicating that it is no longer in use. The termination of a code means that it is no longer valid for billing purposes. It is important for medical coders to stay updated on code changes and ensure they are using the most current codes for accurate billing.

7. Medicare and Insurance Coverage

HCPCS code C9456 falls under the coverage code D, which means that special coverage instructions may apply. The pricing indicator code for this code is 57, indicating that it is priced by other carriers. The multiple pricing indicator code is A, which means that it is not applicable as HCPCS priced under one methodology. Medicare and other insurance companies may have specific coverage policies and reimbursement rates for this code. It is important to verify coverage and reimbursement guidelines with the respective payers.

8. Examples

Here are some examples of scenarios where HCPCS code C9456 may be used:

1. A patient with a fungal infection receives an injection of isavuconazonium sulfate, 1 mg, as part of their treatment plan.
2. A healthcare provider administers an injection of isavuconazonium sulfate, 1 mg, to a patient who is undergoing a surgical procedure.
3. A patient with a compromised immune system receives regular injections of isavuconazonium sulfate, 1 mg, to prevent fungal infections.
4. An oncology patient receives an injection of isavuconazonium sulfate, 1 mg, to manage a fungal infection caused by their weakened immune system.
5. A patient with a severe respiratory infection receives an injection of isavuconazonium sulfate, 1 mg, to treat a suspected fungal complication.